The Mononucleosis Diagnostic Market is steadily expanding as healthcare providers focus on early detection and efficient management of infectious diseases. The market is projected to grow from US$ 151.44 million in 2023 to US$ 222.15 million by 2031, registering a CAGR of 4.9% during 2023–2031. Within this evolving landscape, Mononucleosis Diagnostic Market Dynamics play a crucial role in...